Physician profile
John Patrick Sullivan
NPI 1356353965
$13,326.72
in general payments reported to CMS, 2019-2025
65 companies · $3,101 in 2025
The $3,101 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $890 · 2021: $1,259 · 2022: $1,932 · 2023: $2,465 · 2024: $2,497 · 2025: $3,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,046 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,045.84 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,319.90 | 2021-2025 | Ubrelvy, Qulipta, Duopa |
| Novartis Pharmaceuticals Corporation | $1,029.61 | 2019-2025 | |
| Ge Healthcare | $775.07 | 2019-2025 | |
| Ucb, INC. | $717.87 | 2019-2025 | Zilbrysq, Nayzilam, Fintepla |
| Amgen INC. | $674.81 | 2019-2025 | Uplizna |
| Biogen, INC. | $607.87 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Alexion Pharmaceuticals, INC. | $547.85 | 2019-2025 | Ultomiris, Soliris |
| Acadia Pharmaceuticals INC | $472.52 | 2019-2023 | Nuplazid |
| Argenx US, INC. | $455.85 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Tg Therapeutics, INC. | $352.03 | 2024-2025 | |
| Lundbeck LLC | $337.68 | 2021-2025 | Vyepti |
| Neurelis, INC. | $330.15 | 2021-2025 | Valtoco |
| Genzyme Corporation | $309.27 | 2019-2025 | |
| Genentech USA, INC. | $276.96 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Pfizer INC. | $256.92 | 2023-2025 |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.